Kraig Biocraft Laboratories, Inc.
KBLB
$0.14
$0.001.05%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.53% | -248.48% | 54.79% | -18.13% | 35.70% |
| Total Depreciation and Amortization | -65.75% | 225.76% | 450.75% | -14.93% | 160.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.67% | 1,542.24% | -99.49% | 34.99% | -99.77% |
| Change in Net Operating Assets | 17.30% | -5.41% | 19.24% | 113.99% | -19.34% |
| Cash from Operations | 12.29% | -41.56% | 13.25% | 11.24% | -56.39% |
| Capital Expenditure | 61.90% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1,809.52% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -861.54% | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 19,701.92% | 4,687.33% | 1,154.67% | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 143.44% | 335.35% | 173.89% | 45.23% | -50.80% |